KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Goodwill (2020 - 2023)

Bionano Genomics' Goodwill history spans 3 years, with the latest figure at $77.3 million for Q4 2022.

  • For Q4 2022, Goodwill rose 37.62% year-over-year to $77.3 million; the TTM value through Dec 2022 reached $77.3 million, up 37.62%, while the annual FY2022 figure was $77.3 million, 37.62% up from the prior year.
  • Goodwill for Q4 2022 was $77.3 million at Bionano Genomics, up from $56.3 million in the prior quarter.
  • Across five years, Goodwill topped out at $77.3 million in Q4 2022 and bottomed at $6.9 million in Q3 2020.
  • The 3-year median for Goodwill is $31.7 million (2020), against an average of $35.2 million.
  • The largest YoY upside for Goodwill was 682.94% in 2021 against a maximum downside of 3.34% in 2021.
  • A 3-year view of Goodwill shows it stood at $7.2 million in 2020, then soared by 682.94% to $56.2 million in 2021, then soared by 37.62% to $77.3 million in 2022.
  • Per Business Quant, the three most recent readings for BNGO's Goodwill are $77.3 million (Q4 2022), $56.3 million (Q1 2022), and $56.2 million (Q4 2021).